CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

410.99 USD
-13.17 (-3.1%)
At close: Mar 4, 2026
410.99 USD
0 (0%)
After Hours: 3/4/2026, 8:14:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall CHE gets a fundamental rating of 7 out of 10. We evaluated CHE against 101 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CHE had a positive operating cash flow.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • CHE's Return On Assets of 17.24% is amongst the best of the industry. CHE outperforms 100.00% of its industry peers.
  • CHE has a Return On Equity of 27.08%. This is amongst the best in the industry. CHE outperforms 91.09% of its industry peers.
  • CHE's Return On Invested Capital of 21.08% is amongst the best of the industry. CHE outperforms 95.05% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHE is significantly above the industry average of 9.13%.
  • The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROIC 21.08%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • The Profit Margin of CHE (10.48%) is better than 96.04% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has declined.
  • CHE has a Operating Margin of 14.01%. This is amongst the best in the industry. CHE outperforms 86.14% of its industry peers.
  • In the last couple of years the Operating Margin of CHE has declined.
  • With a decent Gross Margin value of 32.54%, CHE is doing good in the industry, outperforming 63.37% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
Industry RankSector Rank
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CHE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • The number of shares outstanding for CHE has been reduced compared to 1 year ago.
  • CHE has less shares outstanding than it did 5 years ago.
  • CHE has a worse debt/assets ratio than last year.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 11.38 indicates that CHE is not in any danger for bankruptcy at the moment.
  • CHE has a better Altman-Z score (11.38) than 96.04% of its industry peers.
  • CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • The Debt to FCF ratio of CHE (0.03) is better than 93.07% of its industry peers.
  • CHE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CHE (0.01) is better than 84.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 11.38
ROIC/WACC2.42
WACC8.71%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CHE has a Current Ratio of 1.05. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • CHE has a worse Current ratio (1.05) than 62.38% of its industry peers.
  • A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, CHE is in line with its industry, outperforming 41.58% of the companies in the same industry.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.03
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CHE Growth Analysis

3.1 Past

  • The earnings per share for CHE have decreased by -6.70% in the last year.
  • Measured over the past 5 years, CHE shows a small growth in Earnings Per Share. The EPS has been growing by 3.61% on average per year.
  • Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 4.06% in the last year.
  • The Revenue has been growing slightly by 4.00% on average over the past years.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%

3.2 Future

  • CHE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.57% yearly.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.04, CHE is valued on the expensive side.
  • Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 71.29% of the companies in the same industry.
  • CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 16.95, the valuation of CHE can be described as correct.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 70.30% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, CHE is valued a bit cheaper.
Industry RankSector Rank
PE 19.04
Fwd PE 16.95
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
  • CHE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHE is cheaper than 70.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.39
EV/EBITDA 13.75
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.55
PEG (5Y)5.27
EPS Next 2Y12.04%
EPS Next 3Y10.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CHE Dividend Analysis

5.1 Amount

  • CHE has a yearly dividend return of 0.57%, which is pretty low.
  • CHE's Dividend Yield is rather good when compared to the industry average which is at 0.49. CHE pays more dividend than 81.19% of the companies in the same industry.
  • With a Dividend Yield of 0.57, CHE pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.57%

5.2 History

  • The dividend of CHE is nicely growing with an annual growth rate of 10.71%!
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.71%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.95% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (3/4/2026, 8:14:35 PM)

After market: 410.99 0 (0%)

410.99

-13.17 (-3.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners101.64%
Inst Owner Change42.52%
Ins Owners1.52%
Ins Owner Change-1.18%
Market Cap5.66B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target566.61 (37.86%)
Short Float %4.29%
Short Ratio3.2
Dividend
Industry RankSector Rank
Dividend Yield 0.57%
Yearly Dividend2.21
Dividend Growth(5Y)10.71%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)-3.27%
PT rev (3m)-3.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)-0.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 19.04
Fwd PE 16.95
P/S 2.24
P/FCF 17.39
P/OCF 14.58
P/B 5.78
P/tB 24.64
EV/EBITDA 13.75
EPS(TTM)21.59
EY5.25%
EPS(NY)24.25
Fwd EY5.9%
FCF(TTM)23.64
FCFY5.75%
OCF(TTM)28.2
OCFY6.86%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.55
PEG (5Y)5.27
Graham Number185.88
Profitability
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROCE 28.33%
ROIC 21.08%
ROICexc 22.41%
ROICexgc 60.78%
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
FCFM 12.86%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.03
Cap/Depr 96.84%
Cap/Sales 2.48%
Interest Coverage 263.51
Cash Conversion 92.61%
Profit Quality 122.71%
Current Ratio 1.05
Quick Ratio 1.03
Altman-Z 11.38
F-Score6
WACC8.71%
ROIC/WACC2.42
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 8 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.